Papers: 10.1371/journal.pone.0227261

https://doi.org/10.1371/journal.pone.0227261

Interleukin 6 is increased in preclinical HNSCC models of acquired cetuximab resistance, but is not required for maintenance of resistance

Cited by: 6
Author(s): Rachel A. O’Keefe, Neil E. Bhola, David S. Lee, Daniel E. Johnson, Jennifer R. Grandis
Published: over 6 years ago

Software Mentions 1